首页> 外文期刊>Journal of Business Ethics >Ethical Issues in Outsourcing: The Case of Contract Medical Research and the Global Pharmaceutical Industry
【24h】

Ethical Issues in Outsourcing: The Case of Contract Medical Research and the Global Pharmaceutical Industry

机译:外包中的道德问题:合同医学研究与全球制药行业

获取原文
获取原文并翻译 | 示例
       

摘要

The outsourcing of medical research has become a strategic imperative in the global pharmaceutical industry. Spurred by the challenges of competition, the need for speed in drug development, and increasing domestic costs, pharmaceutical companies across the globe continue to outsource critical parts of their value chain activities, namely contract clinical research and drug testing, to sponsors across the globe, typically into emerging mar kets. While it is clear that important ethical issues arise with this practice, unraveling moral responsibility and the allocation of responsibility is not so clear, considering that contracts, by their very definition transfer responsibility from the principal to the agent. This research provides a framework for exploring some of the ethical issues, including attributions of moral responsibility associated with Contract Medical Research. Using a theory of stra tegic and moral behavior, the research shows that both clients and sponsors in contract research have individual and collective responsibility to ensure that due care and diligence is exercised in the performance of clinical research. The research suggests some guidelines for stakeholder action.
机译:医学研究外包已经成为全球制药行业的战略要务。在竞争挑战,药物开发速度的需求以及国内成本上涨的刺激下,全球各地的制药公司继续将其价值链活动的关键部分(合同临床研究和药物测试)外包给全球赞助商,通常进入新兴市场。虽然很明显,这种做法会产生重要的道德问题,但要解除合同的道德责任和责任的分配并不太清楚,因为考虑到合同的定义是将责任从委托人转移到代理人。这项研究提供了一个框架,用于探讨一些道德问题,包括与合同医学研究相关的道德责任归属。使用策略和道德行为理论,研究表明合同研究的客户和发起人均负有个人和集体责任,以确保在临床研究的执行过程中应谨慎谨慎。该研究为利益相关者的行动提出了一些指导方针。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号